1.00 / AMA PRA Category 1 CreditTM 1.00 / ANCC Contact Hour
Provided by Horizon CME
This session is supported by an independent educational grant provided by Quest Diagnostics.
This activity reviews the role of the antinuclear antibody (ANA) test and subserology tests for facilitating a timely diagnosis of autoimmune diseases in patients with clinical suspicion of disease or to rule out other conditions with similar signs and symptoms. The advantages and disadvantages of ANA testing methods will be reviewed as will the roles of various subserology tests. The patient case study offers a unique opportunity for learners to follow a patient with suspected autoimmune disease through the process of test selection and diagnosis, exploring the appropriateness of various medical tests and procedures as recommended by the ABIM Foundation's “Choosing Wisely” initiative.
Primary care providers, including MDs/DOs, NPs, PAs, and other healthcare professionals who manage patients with autoimmune disorders
After completing the activity, the participant should be better able to:
Discuss the importance and role of antinuclear antibody (ANA) testing for timely diagnosis of autoimmune disorders in primary care
Compare and contrast ANA testing methods
Implement strategies for choosing wisely and appropriately regarding ANA and subserology antibody testing
Accreditor Disclosure of Conflicts of Interest Policy
Horizon CME requires instructors, planners, managers and other individuals who are in a position to influence the content of this activity to disclose any real or apparent conflict of interest (COI) which may arise as a result of prospective faculty members’ relevant relationships with drug or device manufacturer(s). Horizon CME is committed to resolving all conflicts of interest and retaining only those speakers with financial interest conflicts that can be reconciled with the goals and educational integrity of the CME activity.
Dr. Lee discloses no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients during the past 12 months.
Dr. Wallace discloses no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients during the past 12 months.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content disclose no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients during the past 12 months.
AMA PRA Category 1 Credit(s)TM
Horizon CME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Horizon CME designates this activity for a maximum of 1.00 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ANCC Contact Hour(s)
This continuing nursing education activity was approved by Oregon Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. Approval valid through 8/20/2021. OCEAN ID #2019-40.
This activity has received OCEAN approval for 1.00 contact hour.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
There are no fees to participate in the activity. Participants must review all activity information, including the learning objectives, disclosure statements, and content. To receive CME credit for participation, participants must complete the posttest (achieving a passing grade of 75% or greater) and program evaluation. Certificates can be printed immediately.